Market Overview:
The global hemostatic gel market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of surgical procedures, rising awareness about hemostatic gels, and technological advancements in the field of hemostasis. Based on type, the fibrin segment is expected to account for the largest share of the global hemostatic gel market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. Fibrin-based products are widely used as sealants and adhesives in minimally invasive surgeries (MIS) owing to their ability to form strong bonds with tissues and prevent blood loss.
Product Definition:
A hemostatic gel is a substance that is used to stop bleeding. It can be applied topically or injected into the tissue. Hemostatic gels work by forming a clot and plugging the wound. They are often used in combination with pressure to help control bleeding.
Fibrin:
Fibrin is a blood clotting agent that helps stop bleeding by forming a barrier around the wound and promoting hemostasis. It is produced in the liver and kidneys as an inactive form called fibrinogen. Fibrinogen finds its way to the site of injury through the blood stream where it gets activated by thrombin or prothrombin which enhances coagulation factors activity resulting in effective hemostasis.
Gelatin:
Gelatin is a protein derived from collagen. It is widely used in pharmaceutical and food industry owing to its property of forming transparent, flexible, elastic gels upon addition of water. Gelatin can be extracted from various sources such as animal skin, fish bones & joints and seaweed.
Application Insights:
The general surgery segment dominated the global hemostatic gel application market in 2017. This is owing to its high usage rate in various procedures, such as transcatheter coronary interventions, cardiac valve procedures and open heart surgeries. In addition, rising healthcare costs coupled with a growing geriatric population are expected to drive the demand for minimally invasive surgeries over the forecast period. This will subsequently increase product consumption during these types of surgeries.
Minimally invasive surgeries require a large number of surgical products due to their increasing popularity and scope of use across various end-use applications. As a result, manufacturers are investing heavily in R&D activities pertaining to new product development for minimally invasive applications only. Some key developments witnessed during recent years include introduction of new technologies that enhance efficiency and effectiveness of existing products or create entirely new ones altogether (ePumps).
Regional Analysis:
North America dominated the global market in 2017 owing to the rising prevalence of cardiovascular diseases and increasing number of surgical procedures performed. According to a study published in NCBI, from 2014 to 2015, around 33.0% of all surgeries were performed on adults (35 years and above) while 66.0% were for patients aged 35 years and younger (excluding neonatal). The U.S.
Growth Factors:
- Increasing incidence of traumatic injuries: The increasing incidence of traumatic injuries is one of the key growth drivers for the hemostatic gel market. Traumatic injuries can cause severe bleeding, which can be effectively controlled by using hemostatic gels.
- Growing demand for minimally invasive surgeries: Minimally invasive surgeries are becoming increasingly popular due to their many advantages over traditional open surgeries. Hemostatic gels are widely used in minimally invasive surgeries to control bleeding quickly and effectively.
- Rising awareness about hemostatic gels: There is a growing awareness about the benefits of using hemostatic gels among surgeons and patients alike. This is helping to drive the growth of the market for hemostatic gels worldwide.
- Technological advancements in hemostasis products: The technological advancements in hemostasis products are helping to improve their efficacy and safety profile, thus driving their adoption among surgeons worldwide .This is aiding the growth of the global market for hemstotic gel products .5) Emergence o new players :The emergence if new players into this field will intensify competition and help bring down prices
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostatic Gel Market Research Report
By Type
Fibrin, Gelatin, Other
By Application
Minimally Invasive Surgery, General Surgery, Others
By Companies
Baxter, J&J, CryoLife, Integra Life Sciences, Advance Medical Solution, BD, CSL Behring, Pfizer, B Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Hemostatic Gel Market Report Segments:
The global Hemostatic Gel market is segmented on the basis of:
Types
Fibrin, Gelatin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Minimally Invasive Surgery, General Surgery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- J&J
- CryoLife
- Integra Life Sciences
- Advance Medical Solution
- BD
- CSL Behring
- Pfizer
- B Braun
Highlights of The Hemostatic Gel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fibrin
- Gelatin
- Other
- By Application:
- Minimally Invasive Surgery
- General Surgery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostatic Gel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostatic gel is a type of medical adhesive that helps to stop bleeding. It is usually applied to the skin and can be used to seal cuts, wounds, or other injuries. Hemostatic gel can also be used as a bandage in cases of minor bleeding.
Some of the major players in the hemostatic gel market are Baxter, J&J, CryoLife, Integra Life Sciences, Advance Medical Solution, BD, CSL Behring, Pfizer, B Braun.
The hemostatic gel market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemostatic Gel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hemostatic Gel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hemostatic Gel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hemostatic Gel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hemostatic Gel Market Size & Forecast, 2020-2028
4.5.1 Hemostatic Gel Market Size and Y-o-Y Growth
4.5.2 Hemostatic Gel Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fibrin
5.2.2 Gelatin
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Minimally Invasive Surgery
6.2.2 General Surgery
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hemostatic Gel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hemostatic Gel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fibrin
9.6.2 Gelatin
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Minimally Invasive Surgery
9.10.2 General Surgery
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fibrin
10.6.2 Gelatin
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Minimally Invasive Surgery
10.10.2 General Surgery
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fibrin
11.6.2 Gelatin
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Minimally Invasive Surgery
11.10.2 General Surgery
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fibrin
12.6.2 Gelatin
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Minimally Invasive Surgery
12.10.2 General Surgery
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fibrin
13.6.2 Gelatin
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Minimally Invasive Surgery
13.10.2 General Surgery
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hemostatic Gel Market: Competitive Dashboard
14.2 Global Hemostatic Gel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter
14.3.2 J&J
14.3.3 CryoLife
14.3.4 Integra Life Sciences
14.3.5 Advance Medical Solution
14.3.6 BD
14.3.7 CSL Behring
14.3.8 Pfizer
14.3.9 B Braun
